It is not a drug, dietary supplement, food additive, cosmetic, or therapeutic agent, and must not be used in or on humans or animals
PubMed beta-Thymosins Background source for thymosin biology and tissue-repair mechanisms
Why Standardizing Decision-Making Matters The real question isn't "What dose should we use?" It's, "How do we create a safe, compliant process?" That looks like: Written protocols Clear eligibility criteria Strong informed consent forms Set follow-up checks Adverse event reporting Staff training Standard workflows protect your patients, your providers, and your spa
Ipamorelin: Discovery and Regulatory History Tracing ipamorelin from the 1970s GHRP tradition through its 1998 characterization at Novo Nordisk, the ghrelin discovery that redefined its target, its postoperative-ileus clinical program, and the FDA 503A compounding review